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1. Introduction 
A number of pyridine nucleotide analogues have 
been prepared by modification or substitution of 
the adenine moiety of nicotinamide adenine dinu- 
cleotide. The hypoxanthine analogue has been pre- 
pared by nitrous acid [l] or enzymatic [2] deami- 
nation of NAD; the l- and 6-hydroxyethyl adenine 
analogues by treatment of NAD with ethylene oxide 
[3] ; the uracil [4, 51, thymine [4, 51, cytosine [5], 
guanine [5] and 6-mercaptopurine [6] analogues 
by the carbodiimide method. In addition, the guanine 
analogue has also been prepared enzymatically from 
GTP and NMN [7], the cytosine analogue by con- 
densation of the mononucleotides in trifluoroacetic 
anhydride by the method of Shuster et al. [9] and 
the 3-iso-AMP analogue by exchange of the nucleo- 
tide with the methyl trioctyl ammonium salt of 
NMN [IO]. 
Following the method of Shuster et al. [9], a 
rapid, large scale preparation of the guanine analogue 
(NGD) has been developed, utilizing NAD and GMP 
as starting materials. NGD is separated from the 
complex reaction mixture of adenine, guanine and 
nicotinamide mono- and dinucleotides by chromato- 
graphy on long columns of Dowex-I-formate. This 
procedure avoids the costly initial preparation of 
NMN and has been scaled up to reaction mixtures 
starting with 2.5 g of NAD. 
* Present address: Department of Biology, Florida Inter- 
national University, Miami, Florida 33144, and the De- 
partment of Biochemistry, University of Miami School 
of Medicine, Miami, Florida 33152, USA. 
270 
2. Methods 
2.1, Preparation of NGD 
Trifluoroacetic anhydride (about 5 g) was cau- 
tiously added to 1 g of a 3: 1 mixture by weight of 
GMP and NAD in a pressure vial. The mixture was 
stirred for 20 hr at room temp. Most of the acetic 
anhydride was removed under reduced pressure; 
the crude nucleotides precipitated with excess ether, 
washed with ether and dried under reduced pressure. 
The product was dissolved in water, adjusted to 
pH 7 with KOH, filtered if necessary and applied 
to Dowex-1-formate columns. Chromatography is 
carried out as previously described for the large 
scale preparation of the thionicotinamide analogues 
of NAD and NADP [ 11.1. Fig. 1 shows a typical 
chromatogram. Three pyridinium compounds are 
detected by their reaction in cyanide. The first com- 
ponent to emerge is free of adenine and guanine 
and is devoid of enzymatic activity. The second 
cyanide reactive component is identified as NAD 
by spectral properties and reactivity in the yeast 
alcohol dehydrogenase (YADH) system. The third 
component, identified as NGD, is weakly active in 
the YADH system. The compound is precipitated 
and dried as described previously [ 1 l] . The yield 
is 18-20% based on the starting NAD. 
The spectra of NGD’, NGDH and NGD.CN are 
shown in fig. 2a, the near UV bands of the cyanide 
and the enzymatically reduced compounds have 
maxima of 325 nm and 338 nm, respectively, indis- 
tinguishable in this regard and in extinction from 
the values for the corresponding NAD derivatives 
[ 12 ] . The spectra in the UV are similar to those of 
North-Holland Publishing Company - Amsterdam 
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Fig. I. Chromatography of the NGD reaction mixture on 
Dowex-l-formate. The nucleotide mixture derived from 
the reaction of 200 mg of NAD and 600 mg of GMP is 
added to a 1.5 X 55 cm column of Dowex-l-formate- X2 
and eluted with a O-3.5 M HCOOH gradient. Fraction 
volume is 4 ml. The peak tube of each component is tested 
for reaction in 1 M KCN; the YADH reaction mixture is 
5% v/v in ethanol and 0.1 M in Tris base. 
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Fig. 3. Effect of NGD concentration on rate in the YADH 
system. The reaction is started by adding enzyme to the 
assay mixture, 2 M in ethanol and 0.1 M in Tris base. Ten 
times as much enzyme is used irr the NGD reaction as in 
the reaction with NAD. 
guanine, with 3 spectral types obtained in acid, 
alkali and at neutrality [ 121 
3. Results and discussion 
3.1. Coenzymatic activity of NGD 
At 0.1 mM, the concentration of pyridine nu- 
cleotide usually employed in assays in the YADH 
system, NGD is reduced at about l/l00 the rate 
of NAD (fig. 3, see also [5]). This difference is 
diminished with increasing NGD concentration; the 
effect of nucleotide concentration on rate appears 
to be cooperative, in contrast to the Michaelian 
Fig. 2. Absorption spectra of NGD and derivatives. (a) 
NGD+ (NGD.OX) in 0.1 M potassium phosphate, pH 7.5, 
NGD.CN in 1.0 M KCN and NGDH in the YADH reaction 
mixture (see fig. 1). (b) UV spectra of NGD in 0.1 N HCl. 
0.002 KOH and in 0.1 M potassium phosphate. pH 7.5. All 
spectra recorded at 40 pg/ml on the Cary-14 recording 
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effect of NAD. Honjo et al. [5] have reported a [2] N.O. Kaplan, S.P. Colowick and M.M. Ciotti, J. 
synergistic effect of NAD and NGD in the YADH Biol. Chem. 194 (1952) 579. 
system. It is possible that the rate dependence on [ 31 H.G. Windmueller and N.O. Kaplan, J. Biol. Chem. 
concentration observed in fig, 3 may explain this 
236 (1961) 2716. 
effect. 
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